Successfully Treated Roseomonas mucosa-induced Peritonitis Diagnosed by Mass Spectrometry

Intern Med. 2024 Aug 15;63(16):2311-2315. doi: 10.2169/internalmedicine.2998-23. Epub 2024 Jan 13.

Abstract

Roseomonas mucosa is difficult to identify using routine analytical techniques. We herein report a case of peritoneal dialysis (PD)-related peritonitis caused by R. mucosa identified using matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry (MS). A 70-year-old woman was admitted to our hospital with PD-related peritonitis. Blood agar medium of dialysate culture derived colony pale pink in color, and the organism was identified as R. mucosa using MALDI-TOF MS. She was successfully treated with ciprofloxacin and meropenem without catheter removal. To our knowledge, this is the first case of R. mucosa peritonitis in which technique failure has been avoided.

Keywords: MADLI-TOF; Roseomonas; mass spectrometry; peritoneal dialysis; peritonitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Ciprofloxacin* / therapeutic use
  • Female
  • Gram-Negative Bacterial Infections / diagnosis
  • Gram-Negative Bacterial Infections / drug therapy
  • Humans
  • Meropenem / therapeutic use
  • Methylobacteriaceae* / isolation & purification
  • Peritoneal Dialysis / adverse effects
  • Peritonitis* / diagnosis
  • Peritonitis* / etiology
  • Peritonitis* / microbiology
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization*
  • Thienamycins / therapeutic use
  • Treatment Outcome

Substances

  • Ciprofloxacin
  • Meropenem
  • Anti-Bacterial Agents
  • Thienamycins